These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

896 related items for PubMed ID: 22517990

  • 1. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King KS, Rao JU, Wesley RA, Adams KT, Pacak K.
    J Natl Cancer Inst; 2012 May 02; 104(9):700-8. PubMed ID: 22517990
    [Abstract] [Full Text] [Related]

  • 2. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.
    J Clin Endocrinol Metab; 2009 Oct 02; 94(10):3922-30. PubMed ID: 19622618
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by 18F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning.
    van Berkel A, Vriens D, Visser EP, Janssen MJR, Gotthardt M, Hermus ARMM, Geus-Oei LF, Timmers HJLM.
    J Nucl Med; 2019 Jun 02; 60(6):745-751. PubMed ID: 30413658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Diagnostic performance of [68Ga]DOTATATE PET/CT, [18F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma.
    Jha A, Patel M, Ling A, Shah R, Chen CC, Millo C, Nazari MA, Sinaii N, Charles K, Kuo MJM, Prodanov T, Saboury B, Talvacchio S, Derkyi A, Del Rivero J, O'Sullivan Coyne G, Chen AP, Nilubol N, Herscovitch P, Lin FI, Taieb D, Civelek AC, Carrasquillo JA, Pacak K.
    Eur Radiol; 2024 Oct 02; 34(10):6488-6498. PubMed ID: 38625612
    [Abstract] [Full Text] [Related]

  • 9. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.
    J Clin Endocrinol Metab; 2010 Jun 02; 95(6):2800-10. PubMed ID: 20371665
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of [18F]FDG-PET prior to [131I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL).
    Takenaka J, Watanabe S, Abe T, Hirata K, Uchiyama Y, Kimura R, Shinohara N, Kudo K.
    Ann Nucl Med; 2023 Jan 02; 37(1):10-17. PubMed ID: 36301465
    [Abstract] [Full Text] [Related]

  • 11. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.
    Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, Hofman MS.
    Cancer Imaging; 2016 Aug 17; 16(1):22. PubMed ID: 27535829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations.
    Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J, Pacak K.
    Endocr Relat Cancer; 2008 Mar 17; 15(1):311-23. PubMed ID: 18310297
    [Abstract] [Full Text] [Related]

  • 14. Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.
    Sait S, Pandit-Taskar N, Modak S.
    Pediatr Blood Cancer; 2017 Nov 17; 64(11):. PubMed ID: 28409892
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, Galli G, Fanti S, Giordano A.
    Nucl Med Commun; 2011 Jul 17; 32(7):575-82. PubMed ID: 21471850
    [Abstract] [Full Text] [Related]

  • 16. A Prospective Comparative Study of 18 F-FDOPA PET/CT Versus 123 I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma.
    Sung C, Lee HS, Lee DY, Kim YI, Kim JE, Lee SJ, Oh SJ, Sung TY, Lee YM, Kim YH, Kim BJ, Koh JM, Lee SH, Ryu JS.
    Clin Nucl Med; 2024 Jan 01; 49(1):27-36. PubMed ID: 38054497
    [Abstract] [Full Text] [Related]

  • 17. 68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma.
    Krokhmal AA, Kwatra N, Drubach L, Weldon CB, Janeway KA, DuBois SG, Kamihara J, Voss SD.
    Pediatr Blood Cancer; 2022 Aug 01; 69(8):e29740. PubMed ID: 35484995
    [Abstract] [Full Text] [Related]

  • 18. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study.
    Xu S, Pan Y, Zhou J, Ju H, Zhang Y.
    Clin Nucl Med; 2022 Apr 01; 47(4):299-304. PubMed ID: 35143455
    [Abstract] [Full Text] [Related]

  • 19. Predictive Factors of Early 18F-Fluorodeoxyglucose-Positron Emission Tomography Response to [131I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and Paragangliomas.
    Takenaka J, Watanabe S, Abe T, Tsuchikawa T, Takeuchi S, Hirata K, Kimura R, Wakabayashi N, Shinohara N, Kudo K.
    Neuroendocrinology; 2024 Apr 01; 114(9):816-826. PubMed ID: 37725921
    [Abstract] [Full Text] [Related]

  • 20. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
    Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI, Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K.
    Eur J Nucl Med Mol Imaging; 2016 Sep 01; 43(10):1784-91. PubMed ID: 26996779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.